R1	Has_value Arg1:T1 Arg2:T2	
R2	Has_index Arg1:T3 Arg2:T4	
R3	Has_temporal Arg1:T1 Arg2:T3	
R4	Has_qualifier Arg1:T5 Arg2:T7	
R5	Has_value Arg1:T6 Arg2:T8	
R6	Has_temporal Arg1:T12 Arg2:T13	
R7	Has_value Arg1:T15 Arg2:T14	
*	OR T11 T12
R8	Subsumes Arg1:T10 Arg2:T11	
*	OR T18 T19
R9	Has_multiplier Arg1:T26 Arg2:T25	
R10	Subsumes Arg1:T24 Arg2:T26	
R11	Has_temporal Arg1:T24 Arg2:T27	
R12	Has_negation Arg1:T29 Arg2:T28	
R13	Has_index Arg1:T30 Arg2:T31	
R14	Has_multiplier Arg1:T24 Arg2:T29	
R15	Has_temporal Arg1:T29 Arg2:T30	
R16	AND Arg1:T37 Arg2:T36	
R17	AND Arg1:T37 Arg2:T35	
R18	AND Arg1:T34 Arg2:T37	
R19	Has_mood Arg1:T34 Arg2:T33	
R20	multi Arg1:T38 Arg2:T39	
R21	AND Arg1:T40 Arg2:T41	
R22	Has_multiplier Arg1:T40 Arg2:T43	
R23	Has_temporal Arg1:T40 Arg2:T44	
R24	Has_temporal Arg1:T34 Arg2:T38	
R25	Has_value Arg1:T48 Arg2:T49	
R26	Has_temporal Arg1:T48 Arg2:T50	
R27	Subsumes Arg1:T10 Arg2:T15	
R28	AND Arg1:T40 Arg2:T42	
T1	Person 9 13	aged
T2	Value 14 31	18 years or older
T3	Temporal 33 76	at the time of signing the informed consent
T4	Reference_point 48 76	signing the informed consent
T5	Condition 127 133	asthma
T7	Qualifier 143 170	primary respiratory disease
T6	Measurement 173 182	ACT score
T8	Value 183 186	<20
T9	Temporal 187 205	at screening visit
T10	Observation 208 219	Non-smokers
T11	Observation 221 233	never smoked
T12	Observation 237 248	not smoking
T13	Temporal 249 262	for >6 months
T14	Value 268 271	<10
T15	Measurement 272 282	pack years
T16	Non-representable 292 372	Pack years = [cigarettes per day smoked/20] multiplied by number of years smoked
T18	Person 376 380	Male
T19	Person 384 390	female
T20	Pregnancy_considerations 418 763	A female subject is eligible to participate if she is not pregnant, not breastfeeding, and at least one of the following conditions applies: (i) Not a woman of childbearing potential (WOCBP). (ii) A WOCBP who agrees to follow the contraceptive guidance during the treatment period and for at least 5 days] after the last dose of study treatment.
T21	Informed_consent 765 912	Capable of giving signed informed consent which includes compliance with the requirements and restrictions listed in the consent form and protocol.
T22	Non-query-able 914 1016	Subject understands and is willing, able, and likely to comply with study procedures and restrictions.
T23	Non-query-able 1018 1110	Subject must be able to read in a language supported by the smart phone app in their region.
T24	Procedure 1138 1157	maintenance therapy
T25	Multiplier 1159 1169	Fixed dose
T26	Drug 1170 1190	combination ICS/LABA
T27	Temporal 1192 1204	for 3 months
T28	Negation 1206 1212	cannot
T29	Multiplier 1218 1230	changed dose
T30	Temporal 1231 1262	in the month prior to screening
T31	Reference_point 1234 1262	the month prior to screening
T32	Non-representable 1263 1517	and be able to change to an equivalent dose of RELVAR/BREO for the duration of the study. Other background asthma medication such as anti-leukotrienes and oral corticosteroids are permitted provided the dose has been stable for 1 month prior to screening
T33	Mood 1536 1543	able to
T34	Procedure 1544 1550	change
T35	Drug 1554 1564	Salbutamol
T36	Drug 1565 1574	Albuterol
T37	Procedure 1575 1585	MDI rescue
T38	Temporal 1586 1615	for the duration of the study
T39	Reference_point 1590 1615	the duration of the study
T40	Condition 1627 1649	capable of withholding
T41	Drug 1650 1659	albuterol
T42	Drug 1660 1670	salbutamol
T43	Multiplier 1671 1691	for at least 6 hours
T44	Temporal 1692 1713	prior to study visits
T46	Non-query-able 1716 2047	Subject must have their own Android or iPhone operating system (IOS) smart phone and a data package suitable for the installation and running of the app and sending and receiving data. Data used by the CIS is approximately 1 megabyte (MB) per month as a maximum; this is less data than a 1 minute video streamed from YouTube (2MB).
T47	Non-query-able 2049 2418	Subjects must be willing and able to download the app on their personal smart phone and keep it turned on for the duration of the study. This will also require Bluetooth to be turned on for duration of the study. Subjects will also have to turn on mobile data for the app for the duration of study; unless travelling and when extra data roaming costs could be incurred.
T48	Measurement 2420 2429	ACT score
T49	Value 2430 2433	<20
T50	Temporal 2434 2456	at randomization visit
